Trademark: 98288528
Word
PATIENTS FIRST. POWERED BY EVIDENCE.
Status
Pending
Status Code
630
Status Date
Monday, January 22, 2024
Serial Number
98288528
Mark Type
4000
Filing Date
Tuesday, November 28, 2023

Trademark Owner History

Classifications
41 educational, training and educational testing services, namely, conducting seminars, conferences and presentations featuring topics in the field of health, medical care and pharmaceutical industries
9 downloadable and on-line non-downloadable technology, namely, software, platforms, digital assets, mobile applications and artificial intelligence in the field of Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis
16 printed materials, namely, brochures, manuals and handbooks featuring topics relating to health, medical and pharmaceutical education, training and testing in connection with patient assistance programs for the pharmaceutical and healthcare industries
38 training and educational services, namely, webcasting, presentations, seminars and other programs featuring topics in the field of health, medical care and pharmaceutical industries
35 consulting services in the cost and payment management of health care, namely, co-pay cards and other benefits; medical cost containment and reimbursement services to improve health, affordability and patient experience; co-pay card services, affordability consulting and program assessment; consulting services featuring analytics and information in the healthcare and pharmaceutical industries during drug development and commercialization, namely, analytics and information in the fields of real world evidence, health economics, outcomes research, payer research and market access; strategic business analysis and business advice regarding benefit management, pharmaceutical end-user behavior and healthcare use behavior; consulting services in the field of pharmacovigilance strategies to ensure regulatory compliance and patient safety in clinical trials and marketed pharmaceuticals involving human subjects; Consulting services in the fields of risk minimization, risk mitigation and Risk Evaluation and Mitigation Strategies; Consulting services in the field of epidemiology
45 safety and efficacy services, namely, risk mitigation and pharmacovigilance services, prescription drug monitoring programs, analyzing clinical data in healthcare databases, clinical trials, health economics and outcomes research in the fields of healthcare and pharmaceuticals, organizing, managing, and tracking data during development of a clinical trial, creating and updating clinical guidelines in the fields of healthcare and pharmaceuticals; consultation services in the field of research compliance, namely, regulatory compliance consultation services in the field of clinical trials involving human subjects; regulatory compliance consultation services in the field of informed consent protocols for clinical trial participants, Pregnancy registries, Pregnancy Root cause analysis, Risk Evaluation and Mitigation Strategy administration, Observational Research Real world Evidence, Real world Data, Knowledge Attitude and Behavior Surveys, Proprietary Risk Evaluation and Mitigation Strategy Platform, Expanded Patient Access Programs, Clinical Trial and Post Marketing Case Processing, Post Marketing Commitments, Post Marketing Requirements, Risk Minimization Plans, Risk Evaluation and Mitigation, Patient HUB, Benefit Investigation, Interventional Clinical Trials, Natural History Studies, Pragmatic Studies Design and Administration of Outcomes Based Agreements (or value based agreements), Federated Registries, Integrated Registries, Decentralized Studies, and Patient Recruitment Strategy
44 healthcare services in the nature of remote and in-person patient support services, namely, patient access and affordability and reimbursement services, nursing, dose administration and patient monitoring; clinical coordination of in-home services, structure and management of our nationwide home health network, structure and management of our nationwide injection network, PAS consulting, CRM design and implementation solutions, various technology partnerships and custom configurations connecting vendors and services, hybrid operating platform designs and deployments
42 medical and scientific research, namely, conducting clinical trials; basic and clinical research in the field of heath care and medicine; on-line non-downloadable technology, namely, software, platforms, applications, artificial intelligence and digital assets used to conduct, monitor, analyze or generate information related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis; non-downloadable software as a service (SAAS) technology platforms related to Clinical Research, Safety Services, Risk Evaluation and Mitigation, Patient Support Services, Evidence Development and Data Analysis

Trademark Events
Mar 18, 2024
Letter Of Protest Evidence Forwarded
Jan 22, 2024
New Application Office Supplied Data Entered
Dec 1, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24